Apex Prime Care Ltd - Period Ending 2023-03-31

Apex Prime Care Ltd - Period Ending 2023-03-31


Apex Prime Care Ltd 04296566 false 2022-04-01 2023-03-31 2023-03-31 The principal activity of the company is domiciliary care. Digita Accounts Production Advanced 6.30.9574.0 true true true true false false false false 04296566 2022-04-01 2023-03-31 04296566 2023-03-31 04296566 bus:OrdinaryShareClass1 2023-03-31 04296566 bus:OrdinaryShareClass2 2023-03-31 04296566 bus:OrdinaryShareClass3 2023-03-31 04296566 bus:OrdinaryShareClass4 2023-03-31 04296566 bus:OrdinaryShareClass5 2023-03-31 04296566 bus:OtherShareClass1 2023-03-31 04296566 bus:OtherShareClass2 2023-03-31 04296566 bus:OtherShareClass3 2023-03-31 04296566 bus:Consolidated 2023-03-31 04296566 core:AcceleratedTaxDepreciationDeferredTax 2023-03-31 04296566 core:OtherDeferredTax 2023-03-31 04296566 core:RetainedEarningsAccumulatedLosses 2023-03-31 04296566 core:ShareCapital 2023-03-31 04296566 core:CurrentFinancialInstruments 2023-03-31 04296566 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 04296566 core:Non-currentFinancialInstruments 2023-03-31 04296566 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 04296566 core:Goodwill 2023-03-31 04296566 core:BetweenOneFiveYears 2023-03-31 04296566 core:BetweenTwoFiveYears 2023-03-31 04296566 core:WithinOneYear 2023-03-31 04296566 core:FurnitureFittingsToolsEquipment 2023-03-31 04296566 core:MotorVehicles 2023-03-31 04296566 bus:FRS102 2022-04-01 2023-03-31 04296566 bus:Audited 2022-04-01 2023-03-31 04296566 bus:FullAccounts 2022-04-01 2023-03-31 04296566 bus:RegisteredOffice 2022-04-01 2023-03-31 04296566 bus:Director1 2022-04-01 2023-03-31 04296566 bus:Director2 2022-04-01 2023-03-31 04296566 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 04296566 bus:OrdinaryShareClass2 2022-04-01 2023-03-31 04296566 bus:OrdinaryShareClass3 2022-04-01 2023-03-31 04296566 bus:OrdinaryShareClass4 2022-04-01 2023-03-31 04296566 bus:OrdinaryShareClass5 2022-04-01 2023-03-31 04296566 bus:OtherShareClass1 2022-04-01 2023-03-31 04296566 bus:OtherShareClass2 2022-04-01 2023-03-31 04296566 bus:OtherShareClass3 2022-04-01 2023-03-31 04296566 bus:Consolidated 2022-04-01 2023-03-31 04296566 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 04296566 1 2022-04-01 2023-03-31 04296566 core:OtherProvisionsContingentLiabilities 2022-04-01 2023-03-31 04296566 core:RetainedEarningsAccumulatedLosses 2022-04-01 2023-03-31 04296566 core:ShareCapital 2022-04-01 2023-03-31 04296566 core:Goodwill 2022-04-01 2023-03-31 04296566 core:NetGoodwill 2022-04-01 2023-03-31 04296566 core:FurnitureFittingsToolsEquipment 2022-04-01 2023-03-31 04296566 core:MotorVehicles 2022-04-01 2023-03-31 04296566 core:OfficeEquipment 2022-04-01 2023-03-31 04296566 core:Subsidiary1 2022-04-01 2023-03-31 04296566 core:Subsidiary1 1 2022-04-01 2023-03-31 04296566 core:Subsidiary2 2022-04-01 2023-03-31 04296566 core:Subsidiary2 1 2022-04-01 2023-03-31 04296566 core:Subsidiary3 2022-04-01 2023-03-31 04296566 core:Subsidiary3 1 2022-04-01 2023-03-31 04296566 core:UKTax 2022-04-01 2023-03-31 04296566 countries:EnglandWales 2022-04-01 2023-03-31 04296566 2022-03-31 04296566 core:RetainedEarningsAccumulatedLosses 2022-03-31 04296566 core:ShareCapital 2022-03-31 04296566 core:Goodwill 2022-03-31 04296566 core:FurnitureFittingsToolsEquipment 2022-03-31 04296566 core:MotorVehicles 2022-03-31 04296566 2021-04-01 2022-03-31 04296566 2022-03-31 04296566 bus:OrdinaryShareClass1 2022-03-31 04296566 bus:OrdinaryShareClass2 2022-03-31 04296566 bus:OrdinaryShareClass3 2022-03-31 04296566 bus:OrdinaryShareClass4 2022-03-31 04296566 bus:OrdinaryShareClass5 2022-03-31 04296566 bus:OtherShareClass1 2022-03-31 04296566 bus:OtherShareClass2 2022-03-31 04296566 bus:OtherShareClass3 2022-03-31 04296566 core:AcceleratedTaxDepreciationDeferredTax 2022-03-31 04296566 core:OtherDeferredTax 2022-03-31 04296566 core:RetainedEarningsAccumulatedLosses 2022-03-31 04296566 core:ShareCapital 2022-03-31 04296566 core:CurrentFinancialInstruments 2022-03-31 04296566 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 04296566 core:Non-currentFinancialInstruments 2022-03-31 04296566 core:Non-currentFinancialInstruments core:AfterOneYear 2022-03-31 04296566 core:Goodwill 2022-03-31 04296566 core:CostValuation 2022-03-31 04296566 core:BetweenOneFiveYears 2022-03-31 04296566 core:BetweenTwoFiveYears 2022-03-31 04296566 core:WithinOneYear 2022-03-31 04296566 core:FurnitureFittingsToolsEquipment 2022-03-31 04296566 core:MotorVehicles 2022-03-31 04296566 1 2021-04-01 2022-03-31 04296566 core:RetainedEarningsAccumulatedLosses 2021-04-01 2022-03-31 04296566 core:ShareCapital 2021-04-01 2022-03-31 04296566 core:Subsidiary1 1 2021-04-01 2022-03-31 04296566 core:Subsidiary2 1 2021-04-01 2022-03-31 04296566 core:Subsidiary3 1 2021-04-01 2022-03-31 04296566 core:UKTax 2021-04-01 2022-03-31 04296566 2021-03-31 04296566 core:RetainedEarningsAccumulatedLosses 2021-03-31 04296566 core:ShareCapital 2021-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 04296566

Apex Prime Care Ltd

Annual Report and Financial Statements

for the Year Ended 31 March 2023

 

Apex Prime Care Ltd

Contents

Company Information

1

Strategic Report

2

Directors' Report

3

Statement of Directors' Responsibilities

4

Independent Auditor's Report

5 to 7

Profit and Loss Account

8

Balance Sheet

9

Statement of Changes in Equity

10

Notes to the Financial Statements

11 to 22

 

Apex Prime Care Ltd

Company Information

Directors

B Patrick

M S Patrick

Registered office

Windsor House
Bayshill Road
Cheltenham
GL50 3AT

Auditors

Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Apex Prime Care Ltd

Strategic Report for the Year Ended 31 March 2023

The directors present their strategic report for the year ended 31 March 2023.

Principal activity

The principal activity of the company is domiciliary care.

Fair review of the business

The results for the year, which are set out in the profit and loss account, show turnover of £30,823,503 (2022 - £31,070,867) and an operating profit of £1,619,188 (2022 - £3,267,739). At 31 March 2023, the company had net assets of £5,029,660 (2022 - £4,737,172). The directors consider the performance for the year and the financial position at the year end to be satisfactory.

Given the nature of the business, the directors are of the opinion that key performance indicators are important. The company uses a number of indicators to monitor and improve the position of the business. Indicators are reviewed and altered to meet changes both in the internal and external environments. The directors do not consider the inclusion of an analysis using key performance indicators to be necessary to assist users of the financial statements in their understanding of the financial performance or position of the company.

Principal risks and uncertainties

The management of the business and the execution of the company's strategy are subject to a number of risks. The key business risks and uncertainties affecting the company are considered to relate to ongoing compliance with current and future legislation affecting the sector.

Approved by the Board on 3 November 2023 and signed on its behalf by:


M S Patrick
Director

 

Apex Prime Care Ltd

Directors' Report for the Year Ended 31 March 2023

The directors present their report and the financial statements for the year ended 31 March 2023.

Directors of the company

The directors who held office during the year were as follows:

B Patrick

M S Patrick

Financial instruments

Objectives and policies

The board constantly monitors the company's trading results and revise projections as appropriate to ensure that the company can meet its future obligations as they fall due.

Price risk, credit risk, liquidity risk and cash flow risk

The company is exposed to the usual credit and cash flow risks associated with selling on credit and manages this through credit control procedures. The company's bank loans and loan stock are subject to price and liquidity risk as disclosed in note 18 to the financial statements.

In accordance with the Financial Reporting Council's 'Going Concern and Liquidity Risk: Guidance for Directors of UK Companies 2009', the directors of all companies are now required to provide disclosures regarding the adoption of the going concern basis of accounting.

The company has sufficient resources available and the directors have prepared forecasts for the next 12 months that indicate that this will continue to be the case and that these cash flows will be sufficient for the company to meet its financing commitments as they fall due. The directors therefore have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future and have continued to adopt the going concern basis in preparing the financial statements.

Employment of disabled persons

The company’s policy is to consider the recruitment of disabled workers for those vacancies that they are able to fill. All necessary assistance with initial training courses is given. Once employed, a career plan is developed so as to ensure suitable opportunities for each disabled person. Arrangements are made, wherever possible, for retraining employees who become disabled, to enable them to perform work identified as appropriate to their aptitudes and abilities.

Employee involvement

The company encourages the involvement of employees in its management through regular departmental meetings.

Future developments

The external environment is expected to remain competitive going forward, however, the directors are confident that the company will continue to improve the current level of performance in the future.

Disclosure of information to the auditors

Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.

Reappointment of auditors

Hazlewoods LLP have expressed their willingness to continue in office.

Approved by the Board on 3 November 2023 and signed on its behalf by:


M S Patrick
Director

 

Apex Prime Care Ltd

Statement of Directors' Responsibilities

The directors are responsible for preparing the Strategic Report, Directors' Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards has been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Apex Prime Care Ltd

Independent Auditor's Report to the Members of Apex Prime Care Ltd

Opinion

We have audited the financial statements of Apex Prime Care Ltd (the 'company') for the year ended 31 March 2023, which comprise the Profit and Loss Account, Balance Sheet, Statement of Changes in Equity, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 31 March 2023 and of its profit for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:

the directors’ use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or

the directors have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the company’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

 

Apex Prime Care Ltd

Independent Auditor's Report to the Members of Apex Prime Care Ltd

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Extent to which the audit was capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We considered the nature of the company’s industry and its control environment and reviewed the company’s documentation of their policies and procedures relating to fraud and compliance with laws and regulations. We also enquired of management about their own identification and assessment of the risks of irregularities.

We obtained an understanding of the legal and regulatory framework that the company operates in and identified the key laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements, including the UK Companies Act and tax legislation, and, those that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company’s ability to operate or to avoid a material penalty.

We discussed among the audit engagement team regarding the opportunities and incentives that may exist within the organisation for fraud and how and where fraud might occur in the financial statements.

 

Apex Prime Care Ltd

Independent Auditor's Report to the Members of Apex Prime Care Ltd

In common with all audits conducted in accordance with ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override of controls. In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments; assessed whether the judgements made in accounting estimates are indicative of a potential bias; and evaluated the business rationale of any significant transactions that are unusual or outside the normal course of business.

In addition to the above, our procedures to respond to the risks identified included the following:

reviewing financial statement disclosures by testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;

performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatements due to fraud;

enquiring of management concerning actual and potential litigation and claims and instances of non-compliance with laws and regulations; and

reading minutes of meetings of those charged with governance.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion. There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it.

A further description of our responsibilities is available on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.





Joanne Hartness (Senior Statutory Auditor)
For and on behalf of Hazlewoods LLP, Statutory Auditor

Windsor House
Bayshill Road
Cheltenham
GL50 3AT

3 November 2023

 

Apex Prime Care Ltd

Profit and Loss Account for the Year Ended 31 March 2023

Note

2023
£

2022
£

Turnover

3

30,823,503

31,070,867

Cost of sales

 

(21,782,324)

(21,360,827)

Gross profit

 

9,041,179

9,710,040

Administrative expenses

 

(7,421,991)

(6,442,301)

Operating profit

5

1,619,188

3,267,739

Other interest receivable and similar income

6

4,396

165,518

Amounts written off investments

 

-

(160,608)

Interest payable and similar charges

7

(134,004)

(227)

Profit before tax

 

1,489,580

3,272,422

Taxation

12

(397,092)

(651,018)

Profit for the financial year

 

1,092,488

2,621,404

The above results were derived from continuing operations.

The company has no other comprehensive income for the year.

 

Apex Prime Care Ltd

(Registration number: 04296566)
Balance Sheet as at 31 March 2023

Note

2023
 £

2022
 £

Fixed assets

 

Intangible assets

13

4,656,584

3,661,460

Tangible assets

14

1,168,119

729,197

Investments

15

448,218

448,218

 

6,272,921

4,838,875

Current assets

 

Debtors

16

4,279,251

2,801,432

Cash at bank and in hand

 

455,154

2,502,490

 

4,734,405

5,303,922

Creditors: Amounts falling due within one year

17

(5,456,145)

(3,846,297)

Net current (liabilities)/assets

 

(721,740)

1,457,625

Total assets less current liabilities

 

5,551,181

6,296,500

Creditors: Amounts falling due after more than one year

17

(521,521)

(1,559,328)

Net assets

 

5,029,660

4,737,172

Capital and reserves

 

Called up share capital

20

4

4

Profit and loss account

5,029,656

4,737,168

Total equity

 

5,029,660

4,737,172

Approved and authorised by the Board on 3 November 2023 and signed on its behalf by:
 


M S Patrick
Director

 

Apex Prime Care Ltd

Statement of Changes in Equity for the Year Ended 31 March 2023

Share capital
£

Profit and loss account
£

Total
£

At 1 April 2022

4

4,737,168

4,737,172

Profit for the year

-

1,092,488

1,092,488

Dividends

-

(800,000)

(800,000)

At 31 March 2023

4

5,029,656

5,029,660

Share capital
£

Profit and loss account
£

Total
£

At 1 April 2021

4

3,962,264

3,962,268

Profit for the year

-

2,621,404

2,621,404

Dividends

-

(1,846,500)

(1,846,500)

At 31 March 2022

4

4,737,168

4,737,172

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Name of parent of group

These financial statements are consolidated in the financial statements of Apex Prime Care Holdings Limited.

The financial statements of Apex Prime Care Holdings Limited may be obtained from Companies House.

Group accounts not prepared

The company has taken advantage of the exemption in section 398 of the Companies Act 2006 from the requirement to prepare consolidated financial statements, on the grounds that it is consolidated in the accounts of Apex Prime Care Holdings Limited.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company. The company recognises revenue when:The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Motor vehicles

20% straight line

Fixtures and fittings

20% straight line

Office equipment

20% straight line

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Negative goodwill arising on an acquisition is recognised on the face of the balance sheet on the acquisition date and subsequently the excess up to the fair value of non-monetary assets acquired is recognised in profit or loss in the periods in which the non-monetary assets are recovered.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

Straight line over 10 years

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Balance Sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the Profit and Loss Account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

Financial instruments (continued)

Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

3

Revenue

The total turnover of the company has been derived from its principal activity wholly undertaken in the United Kingdom.

 

4

Other operating income

The analysis of the company's other operating income for the year is as follows:

2023
£

2022
£

Government grants

-

2,197,364

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

 

5

Operating profit

Arrived at after charging:

2023
 £

2022
 £

Depreciation expense

250,475

120,606

Amortisation expense

523,037

453,431

Loss/(profit) on disposal of property, plant and equipment

1,440

(26,884)

 

6

Other interest receivable and similar income

2023
£

2022
£

Interest income on bank deposits

4,396

4,910

Dividend income

-

160,608

4,396

165,518

 

7

Interest payable and similar expenses

2023
£

2022
£

Interest on bank overdrafts and borrowings

134,004

227

 

8

Written off fixed asset investments

2023
£

2022
£

Written off fixed asset investments

-

160,608

 

9

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2023
 £

2022
 £

Wages and salaries

23,501,316

22,815,945

Social security costs

1,924,900

1,658,113

Pension costs, defined contribution scheme

403,430

395,720

25,829,646

24,869,778

The average number of persons employed by the company (including directors) during the year, analysed by category was as follows:

2023
 No.

2022
 No.

Average number of employees

1,302

1,337

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

 

10

Directors' remuneration

The directors' remuneration for the year was as follows:

2023
£

2022
£

Remuneration

69,397

21,292

Contributions paid to money purchase schemes

5,321

20,133

74,718

41,425

During the year the number of directors who were receiving benefits and share incentives was as follows:

2023
No.

2022
No.

Accruing benefits under money purchase pension scheme

1

3

 

11

Auditors' remuneration

2023
£

2022
£

Audit of the financial statements

10,000

10,000


 

 

12

Taxation

Tax charged/(credited) in the profit and loss account

2023
 £

2022
 £

Current taxation

UK corporation tax

382,683

701,451

UK corporation tax adjustment to prior periods

31,135

-

413,818

701,451

Deferred taxation

Arising from origination and reversal of timing differences

(16,726)

(50,433)

Tax expense in the income statement

397,092

651,018

The tax on profit before tax for the year is higher than the standard rate of corporation tax in the UK (2022 - higher than the standard rate of corporation tax in the UK) of 19% (2022 - 19%).

The differences are reconciled below:

2023
£

2022
£

Profit before tax

1,489,580

3,272,422

Corporation tax at standard rate

283,020

621,760

Effect of expense not deductible in determining taxable profit (tax loss)

124,365

81,823

Increase in UK and foreign current tax from adjustment for prior periods

31,135

-

Tax increase/(decrease) from effect of capital allowances and depreciation

2,880

(52,565)

Tax decrease arising from group relief

(44,308)

-

Total tax charge

397,092

651,018

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

Deferred tax

Deferred tax assets and liabilities

2023

Asset
£

Accelerated tax depreciation

44,608

Short term timing differences

30,379

74,987

2022

Asset
£

Accelerated tax depreciation

51,386

Short term timing differences

6,875

58,261

 

13

Intangible assets

Goodwill
 £

Cost

At 1 April 2022

5,476,926

Additions acquired separately

1,518,161

At 31 March 2023

6,995,087

Amortisation

At 1 April 2022

1,815,466

Amortisation charge

523,037

At 31 March 2023

2,338,503

Carrying amount

At 31 March 2023

4,656,584

At 31 March 2022

3,661,460

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

 

14

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost

At 1 April 2022

297,015

898,602

1,195,617

Additions

38,455

575,996

614,451

Hived up on acquisition

36,047

75,750

111,797

Disposals

-

(89,606)

(89,606)

At 31 March 2023

371,517

1,460,742

1,832,259

Depreciation

At 1 April 2022

290,101

176,319

466,420

Charge for the year

21,815

228,660

250,475

Eliminated on disposal

-

(52,755)

(52,755)

At 31 March 2023

311,916

352,224

664,140

Carrying amount

At 31 March 2023

59,601

1,108,518

1,168,119

At 31 March 2022

6,914

722,283

729,197

 

15

Investments

2023
£

2022
£

Investments in subsidiaries

448,218

448,218

Subsidiaries

£

Cost and carrying amount

At 1 April 2022 and at 31 March 2023

448,218

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

     

2023

2022

Subsidiary undertakings

Alexander's Care and Support Limited

England and Wales

Ordinary

100%

100%

Brooker Care Limited

England and Wales

Ordinary

100%

100%

Care2Connect Limited

England and Wales

Ordinary

100%

100%

The principal activity of all subsidiaries is domiciliary care apart from Alexander's Care and Support Limited where the company is now dormant.

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

 

16

Debtors

Note

2023
 £

2022
 £

Trade debtors

 

3,523,669

2,016,189

Amounts owed by related parties

24

26,711

375,288

Other debtors

 

194,280

234,273

Prepayments

 

459,604

117,421

Deferred tax assets

12

74,987

58,261

   

4,279,251

2,801,432

 

17

Creditors

Note

2023
 £

2022
 £

Due within one year

 

Loans and borrowings

18

2,981,476

648,074

Trade creditors

 

213,041

33,977

Amounts due to related parties

24

69,750

-

Social security and other taxes

 

557,819

365,076

Outstanding defined contribution pension costs

 

283,629

64,188

Other creditors

 

197,852

1,144,771

Accrued expenses

 

787,686

953,818

Corporation tax liability

12

167,544

449,451

Deferred income

 

197,348

186,942

 

5,456,145

3,846,297

Due after one year

 

Loans and borrowings

18

521,521

1,559,328

 

18

Loans and borrowings

2023
£

2022
£

Current loans and borrowings

Bank borrowings

2,753,967

469,319

HP and finance lease liabilities

227,509

178,755

2,981,476

648,074

2023
£

2022
£

Non-current loans and borrowings

Bank borrowings

-

1,202,300

HP and finance lease liabilities

521,521

357,028

521,521

1,559,328

The bank loans are made up of two separate loans. The loans are repayable in equal quarterly instalments, with the termination dates falling in 2025 and 2028. The interest rate of the loans are 8% and 9% and the loans are secured by fixed and floating charges over the companies properties and assets.

Due to a breach of covenants at the year end all the bank borrowings have been shown as due within one year.

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

 

19

Pension and other schemes

Defined contribution pension scheme

The company operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the company to the scheme and amounted to £403,430 (2022 - £395,720).

Contributions totalling £283,629 (2022 - £64,188) were payable to the scheme at the end of the year and are included in creditors.

 

20

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

A Ordinary shares of £0.50 each

1

0.50

1

0.50

B Ordinary shares of £0.50 each

1

0.50

1

0.50

C Ordinary shares of £0.50 each

1

0.50

1

0.50

D Ordinary shares of £0.50 each

1

0.50

1

0.50

E Ordinary shares of £0.50 each

1

0.50

1

0.50

F Ordinary shares of £0.50 each

1

0.50

1

0.50

G Ordinary shares of £0.50 each

1

0.50

1

0.50

H Ordinary shares of £0.50 each

1

0.50

1

0.50

 

8

4

8

4

Rights, preferences and restrictions

The different classes of share referred to above carry separate rights to dividends but, in all other significant respects, rank pari passu.

 

Apex Prime Care Ltd

Notes to the Financial Statements for the Year Ended 31 March 2023

 

21

Obligations under leases and hire purchase contracts

Finance leases

The total of future minimum lease payments is as follows:

2023
£

2022
£

Not later than one year

338,331

178,755

Later than one year and not later than five years

521,521

357,028

859,852

535,783

Operating leases

The total of future minimum lease payments is as follows:

2023
£

2022
£

Not later than one year

368,151

345,746

Later than one year and not later than five years

448,931

433,114

817,082

778,860

 

22

Dividends

2023
 £

2022
 £

Dividends paid

800,000

1,846,500

 

23

Contingent liabilities

The company is party to cross guarantees with Apex Prime Care Holdings Limited for the bank debt due from Apex Prime Care Holdings Limited, which amounted to £3,655,068,at 31 March 2023. The bank loans are secured by a floating charge on the assets of the company.

 

24

Related party transactions

Key management personnel are considered to be the directors of the company and key management personnel compensation is disclosed in note 10 to the financial statements.

During a prior year the company advanced a loan of £100,000 to M S Patrick. Interest is charged on this loan at a rate of 4%, and there are no fixed repayment terms. As at the balance sheet date, £100,000 (2022 - £100,000) was outstanding by M S Patrick with a maximum balance of £100,000 during the year.

During the prior year the company advanced a loan of £50,000 to Apex Property (Management and Lettings) Limited a company under common control. During the year this loan was fully provided against as a bad debt. At the balance sheet date £50,000 (2022 - £50,000) was outstanding with a maximum balance of £50,000 during the year.

 

25

Parent and ultimate parent undertaking

The company's immediate and ultimate parent is Apex Prime Care Holdings Limited, incorporated in England & Wales.

 The ultimate controlling party is M S Patrick, director of the company.